Dow Down 0.10% Nasdaq Up 0.24%

ImmunoGen, Inc. (IMGN)

-NasdaqGS
2.78 Down 0.03(1.07%) Jul 26, 4:00PM EDT
|After Hours : 2.81 Up 0.03 (1.08%) Jul 26, 7:17PM EDT
Prev Close:2.81
Open:2.80
Bid:2.70 x 200
Ask:2.87 x 300
1y Target Est:8.50
Beta:2.042
Next Earnings Date: 4-Aug-16IMGN Earnings announcement
Day's Range:2.78 - 2.88
52wk Range:2.68 - 18.78
Volume:810,331
Avg Vol (3m):2,356,420
Market Cap:242.07M
P/E (ttm):N/A
EPS (ttm):-1.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IMGNDown 1.07%242.07M
SGENDown 1.62%6.14B
PFEUp 0.14%223.37B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :-1.54
Quarterly EPS Est (Jun-16) :-0.39
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugates technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback